BillionToOne, Inc. BLLN Weighted Average Exercise Price of Exercisable Options

Weighted Average Exercise Price of Exercisable Options at other companies

BillionToOne, Inc. BLLN

$7.04—

Ondas, Inc. ONDS

$3.51-23.7%

TFS FinancialTFSL

$15.81+2.7%

Dolby Laboratories, Inc.DLB

$72.66+1.7%

Tango TherapeuticsTNGX

$7.91+20.4%

Lantheus HoldingsLNTH

$69.37+13.9%

Other financials

Income statement

See full

Revenue$108.4M+83.8%

Gross profit$79.1M+108%

Operating income$17.8M+870%

Net income$18.0M+551%

EPS (diluted)$0.34+187%

Balance sheet

See full

Cash & equivalents$537.5M+181%

Total debt$144.2M—

Total equity$505.6M+300%

Total assets$700.7M—

Cash flow

See full

Operating cash flow$15.4M+488%

CapEx$4.5M+90.5%

Free cash flow$11.0M+3,842%

Valuation

See full

Market cap$4.84B—

Enterprise value$4.44B—

P/E163.1×—

P/S13.6×—

Profitability

See full

Gross margin70.4%—

Operating margin-96.9%—

Net margin8.4%—

FCF margin-83.4%—

Returns & leverage

See full

Return on equity23.5%—

Debt / equity0.3×—

Current ratio10.9×—

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's weighted average exercise price of exercisable options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BillionToOne, Inc. 's weighted average exercise price of exercisable options?: BillionToOne, Inc. (BLLN) reported weighted average exercise price of exercisable options of $7.04 in Q1 2026.
What does weighted average exercise price of exercisable options mean?: This metric represents the average price at which holders of currently exercisable share-based payment options can purchase company stock. It provides insight into the potential dilution impact and the alignment of employee incentives with shareholder value.